SIGA Announces New Contract Awarded by U.S. Department of Defense for the Procurement of $9 Million of TPOXX®
21 août 2024 16h00 HE
|
SIGA Technologies Inc.
NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company and leader in infectious diseases, today announced a new contract...
Topline Results from PALM 007 Study of SIGA’s Tecovirimat in Treatment of Mpox Released
15 août 2024 07h35 HE
|
SIGA Technologies Inc.
Preliminary analysis shows the study did not reach statistical significance on its primary endpoint of tecovirimat being superior to placebo in lesion resolution for all patientsResults suggest...
SIGA Reports Financial Results for Three and Six Months Ended June 30, 2024
01 août 2024 16h05 HE
|
SIGA Technologies Inc.
Generated Product Sales of $21 Million in the Second Quarter, and $45 Million in the Six Months Ended June 30, 2024Received $113 Million Procurement Order from U.S. Government for Oral TPOXX in...
SIGA to Host Business Update Call on August 1 Following Release of Second-Quarter 2024 Financial Results
25 juil. 2024 07h30 HE
|
SIGA Technologies Inc.
NEW YORK, July 25, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and...
SIGA Announces U.S. Government Procurement Order of $113 Million for Oral TPOXX®
19 juil. 2024 08h00 HE
|
SIGA Technologies Inc.
NEW YORK, July 19, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that the U.S. Department of Health and Human...
SIGA Announces Agreement to Sell TPOXX® to ASEAN Member States
17 juin 2024 16h05 HE
|
SIGA Technologies Inc.
NEW YORK, June 17, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc., a commercial-stage pharmaceutical company focused on global health and infectious diseases, announced today an agreement to...
SIGA Reports Financial Results for Three Months Ended March 31, 2024
07 mai 2024 16h05 HE
|
SIGA Technologies Inc.
Generated Product Sales of $24 Million and Pre-tax Operating Income of $11 MillionCorporate Update Conference Call Today at 4:30 PM ET NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies,...
SIGA Technologies to Host Business Update Call on May 7 Following Release of First-Quarter 2024 Financial Results
01 mai 2024 17h00 HE
|
SIGA Technologies Inc.
NEW YORK, May 01, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and...
SIGA Amends International Promotion Agreement with Meridian to Enhance International Growth Opportunities of Oral TPOXX®
01 avr. 2024 16h05 HE
|
SIGA Technologies Inc.
NEW YORK, April 01, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on health security and infectious disease, announced today that...
SIGA Names Larry Miller General Counsel
25 mars 2024 07h30 HE
|
SIGA Technologies Inc.
NEW YORK, March 25, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on health security and infectious diseases, announced the...